摘要
目的探讨对新生儿肺透明膜病采取改良气管内滴入肺表面活性物质治疗的临床效果。方法本次选择2017年1月—2018年1月本院收治的80例新生儿肺透明膜病患者为研究对象,根据随机表法将所有患者分为两组,各40例。采取不同治疗方式,比较两组患者的临床效果。结果两组临床相关指标差异具有统计学意义(P<0.05)。结论改良气管内滴入肺表面活性物质的临床治疗效果更佳。
Objective To explore the clinical effect ofmodified intratracheal instillation of lung surface active substance in treatment ofneonatal pulmonary hyaline membrane. Methods In this study, 80 cases of neonatal pulmonary hyaline membrane patients admitted to the hospital from January 2017 to January 2018 were selected as the study subjects. According to the random table method, all patients were divided into two groups, each with 40 cases. The clinical effects of the two groups were compared by different treatment methods. Results The differences between the two groups of clinical indicators were statistically significant（P〈0.05）. Conclusion The effect of modified intratracheal instillation of lung surface active substance is better.
作者
鞠秀明
刘昕鑫
JU Xiuming;LIU Xinxin(Neonatal Department,Jilin Children＇s Hospital,Jilin Jilin 132001,China)
出处
《中国卫生标准管理》
2018年第11期83-85,共3页
China Health Standard Management
关键词
改良
气管内滴入
肺表面活性物质
新生儿
肺透明膜病
improvement
intratracheal instillation
lung surface active substance
the newborn
pulmonary hyaline membrane disease
